Category Specific RSS

News

Top podiatry operator Healthia, makes big push in Victoria with 12 clinic acquisition

Allied health services group Healthia (ASX: HLA) has continued its expansion as Australia’s largest operator podiatry clinics, today announcing the acquisition of 12 clinics in Victoria to significantly expand its healthcare offerings in the State. 

Secured for a total consideration of $5 million, the 12 new clinics are forecast to deliver Healthia with $4.4m revenue and $1.1m EBITDA annually. This will be added to the company’s strong H1 results where Healthia reported $44.2m revenue and $5.7m EBITDA which represented year-on-year growth of +50.2% and +33.7% respectively. 

“The completion of this acquisition strengthens the Company’s position as the largest podiatry clinic operator in Australia,” said Healthia CEO and Managing Director, Wesley Coote. 

“We are very excited to be attracting clinics of this scale and stature to the network and we look forward to continuing our acquisitive growth trajectory into the future.”

The acquisitions bring Healthia’s national network of clinics to 93 podiatry, 43 physiotherapy and 10 hand therapy. Newly acquired clinics will also gain the benefit of Healthia’s ancillary businesses DBS Medical Supplies and iOrthotics – Australia’s largest manufacturer of 3D-printed orthotics.

Funded by free cash flow and deferred vendor terms, the acquisition of new Victorian clinics will see Healthia meet their target of deploying $15m annually for clinic acquisitions targeting EBITDA multiple of around 4x. 

For FY20, Healthia will have deployed $18m, of which only $12.6m is cash and $3.4m in unlisted Clinic Class Shares, to secure $4.2m EBITDA annually. 

Core to the strong financial returns have been Healthia’s shared resources where clinics have been able to capitalise on floor space by integrating podiatry services into physio clinics and vice-versa. Within the podiatry network of 93 clinics, clinicians also gain access to iOrthotics which can produce orthotics at much greater scale via 3D printing and lower cost than traditional hand-crafted means.

Highlighting the industry’s shift towards 3D printed products, Healthia launched a new iOrthotics manufacturing facility in January capable of printing 30,000 pairs annually and gaining exposure to the valuable North American healthcare market.  

As per Government directives, Healthia’s network of allied healthcare clinics have remained open through COVID-19, providing essential community services which have assisted in alleviating pressure from the public health system through the coronavirus pandemic.

 

*Owners of this website are shareholders in a company mentioned in this article and have been engaged by them to assist in investor communications

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago